The elucidation of molecular targets of PPAR agonists and metabolic pathways that are governed by these target genes may lead to the discovery of new pharmacological agents and the repurposing of existing drugs for therapeutic intervention in cardiac diseases. Here, PPARA is linked to heart disorder.